Association between symptoms in irritable bowel syndrome with diarrhea (IBS-D): A pooled correlation and tricomposite endpoint analysis of two phase 3, randomized, placebo-controlled, rifaximin trials

被引：0

作者：

Staller, K. ^{[1
]}

Lacy, B. E. ^{[2
]}

Sayuk, G. S. ^{[3
]}

Rao, S. S. C. ^{[4
]}

Karsan, H. A. ^{[5
]}

Neshatiana, L. ^{[6
]}

Lunsford, T. N. ^{[7
]}

Allen, C. ^{[8
]}

Heimanson, Z. ^{[8
]}

Brenner, D. M. ^{[9
]}

机构：

[1] Harvard Med Sch, Boston, MA USA

[2] Mayo Clin, Jacksonville, FL USA

[3] St Louis Vet Affairs Med Ctr, St Louis, MO USA

[4] Augusta Univ, Augusta, GA USA

[5] Atlanta Gastroenterol Associates, Atlanta, GA USA

[6] Stanford Univ, Stanford, CA USA

[7] Mayo Clin, Scottsdale, AZ USA

[8] Salix Pharmaceut, Bridgewater, NJ USA

[9] Northwestern Univ, Chicago, IL USA

来源：

NEUROGASTROENTEROLOGY AND MOTILITY | 2023年 / 35卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

148

引用

页数：2

共 50 条

[21] A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF FECAL MICROBIOTA TRANSPLANTATION CAPSULES (FMTC) FOR THE TREATMENT OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D)
Aroniadis, Olga C.
Brandt, Lawrence J.
Oneto, Caterina
Feuerstadt, Paul
Sherman, Alex
Wolkoff, Allan W.
Downs, Ian A.
Zanetti-Yabur, Alana
Ramos, Yolanda
Cotto, Candace L.
Kassam, Zain
Elliott, Ryan J.
Rosenbaum, Robert
Budree, Shrish
Sadovsky, Rotem Gura
Timberlake, Sonia
Swanson, Paige
Kim, Mimi
Keller, Marla J.
GASTROENTEROLOGY, 2018, 154 (06) : S154 - S155
[22] Irritable bowel syndrome with diarrhea (IBS-D) treated with moxibustion on heat-sensitive acupoints: a randomized controlled trial
Hu Dan
Kang Ming-fei
Xiong Jun
Deng Peng
WORLD JOURNAL OF ACUPUNCTURE-MOXIBUSTION, 2012, 22 (02) : 1 - 5
[23] Rifaximin for Improving Abdominal Pain and Bloating Symptoms in Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) Using Modified Definitions of Pain Response
Lacy, Brian E.
Heimanson, Zeev
Pimentel, Mark
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S263 - S263
[24] RIFAXIMIN FOR IMPROVING ABDOMINAL PAIN AND BLOATING SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) USING MODIFIED DEFINITIONS OF PAIN RESPONSE
Lacy, Brian E.
Heimanson, Zeev
Pimentel, Mark
GASTROENTEROLOGY, 2019, 156 (06) : S92 - S93
[25] Rifaximin for improving abdominal pain and bloating symptoms in patients with irritable bowel syndrome with diarrhea (IBS-D) using modified definitions of pain response
Lacy, B.
Heimanson, Z.
Pimente, M.
NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
[26] EFFECT OF ELUXADOLINE ON ABDOMINAL AND BOWEL SYMPTOMS OVER TIME IN PHASE 3 CLINICAL TRIALS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHOEA (IBS-D)
Harris, L. A.
Lucak, S.
Chang, L.
Dove, L. S.
Covington, P. S.
GUT, 2016, 65 : A122 - A123
[27] Clonidine in diarrhea-predominant irritable bowel syndrome (D-IBS): A randomized, placebo-controlled, dose-response study
Camilleri, M
Kim, DY
McKinzie, S
Kim, HJ
Burton, DD
Thomforde, GM
Zinsmeister, AR
GASTROENTEROLOGY, 2002, 122 (04) : A59 - A59
[28] Cilansetron is efficacious in treating diarcheal symptoms in irritable bowel syndrome with diarrhea predominance (IBS-D) over 3 months
Miner, PB
Pruitt, RE
Carter, F
Caras, S
Krause, G
Steinborn, C
GASTROENTEROLOGY, 2005, 128 (04) : A29 - A29
[29] Efficacy of Serotonin Type 3 Receptor Antagonist Ramosetron on Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-Like Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Tomita, Toshihiko
Fukui, Hirokazu
Morishita, Daisuke
Mori, Sumire
Oshima, Tadayuki
Shinzaki, Shinichiro
Miwa, Hiroto
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
[30] Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials
Schoenfeld, P.
Pimentel, M.
Chang, L.
Lembo, A.
Chey, W. D.
Yu, J.
Paterson, C.
Bortey, E.
Forbes, W. P.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1161 - 1168

← 1 2 3 4 5 →